China
· Delayed Price · Currency is CNY Topchoice Medical Co. Statistics
Total Valuation
Topchoice Medical Co. has a market cap or net worth of CNY 21.84 billion. The enterprise value is 23.02 billion.
| Market Cap | 21.84B |
| Enterprise Value | 23.02B |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
Topchoice Medical Co. has 447.29 million shares outstanding. The number of shares has decreased by -0.37% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 447.29M |
| Shares Change (YoY) | -0.37% |
| Shares Change (QoQ) | +1.49% |
| Owned by Insiders (%) | 3.79% |
| Owned by Institutions (%) | 17.73% |
| Float | 278.76M |
Valuation Ratios
The trailing PE ratio is 45.05 and the forward PE ratio is 50.73. Topchoice Medical Co.'s PEG ratio is 5.28.
| PE Ratio | 45.05 |
| Forward PE | 50.73 |
| PS Ratio | 7.55 |
| PB Ratio | 5.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 62.45 |
| P/OCF Ratio | n/a |
| PEG Ratio | 5.28 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.29, with an EV/FCF ratio of 65.83.
| EV / Earnings | 47.26 |
| EV / Sales | 7.95 |
| EV / EBITDA | 26.29 |
| EV / EBIT | 33.63 |
| EV / FCF | 65.83 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.85 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 1.61 |
| Debt / FCF | 4.02 |
| Interest Coverage | 11.49 |
Financial Efficiency
Return on equity (ROE) is 13.12% and return on invested capital (ROIC) is 7.48%.
| Return on Equity (ROE) | 13.12% |
| Return on Assets (ROA) | 7.11% |
| Return on Capital (ROIC) | 7.48% |
| Revenue Per Employee | 473,392 |
| Profits Per Employee | 79,642 |
| Employee Count | 6,115 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 73.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.12% in the last 52 weeks. The beta is 0.60, so Topchoice Medical Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -18.12% |
| 50-Day Moving Average | 49.88 |
| 200-Day Moving Average | 44.99 |
| Relative Strength Index (RSI) | 41.63 |
| Average Volume (20 Days) | 10,770,467 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Topchoice Medical Co. had revenue of CNY 2.89 billion and earned 487.01 million in profits. Earnings per share was 1.08.
| Revenue | 2.89B |
| Gross Profit | 1.10B |
| Operating Income | 684.42M |
| Pretax Income | 693.66M |
| Net Income | 487.01M |
| EBITDA | 771.41M |
| EBIT | 684.42M |
| Earnings Per Share (EPS) | 1.08 |
Balance Sheet
The company has 597.94 million in cash and 1.41 billion in debt, giving a net cash position of -808.88 million or -1.81 per share.
| Cash & Cash Equivalents | 597.94M |
| Total Debt | 1.41B |
| Net Cash | -808.88M |
| Net Cash Per Share | -1.81 |
| Equity (Book Value) | 4.50B |
| Book Value Per Share | 9.23 |
| Working Capital | 408.83M |
Cash Flow
In the last 12 months, operating cash flow was 861.02 million and capital expenditures -511.37 million, giving a free cash flow of 349.65 million.
| Operating Cash Flow | 861.02M |
| Capital Expenditures | -511.37M |
| Free Cash Flow | 349.65M |
| FCF Per Share | 0.78 |
Margins
Gross margin is 38.01%, with operating and profit margins of 23.64% and 16.82%.
| Gross Margin | 38.01% |
| Operating Margin | 23.64% |
| Pretax Margin | 23.96% |
| Profit Margin | 16.82% |
| EBITDA Margin | 26.65% |
| EBIT Margin | 23.64% |
| FCF Margin | 12.08% |
Dividends & Yields
This stock pays an annual dividend of 0.31, which amounts to a dividend yield of 0.64%.
| Dividend Per Share | 0.31 |
| Dividend Yield | 0.64% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 31.00% |
| Buyback Yield | 0.37% |
| Shareholder Yield | 1.00% |
| Earnings Yield | 2.22% |
| FCF Yield | 1.60% |
Stock Splits
The last stock split was on July 5, 2024. It was a forward split with a ratio of 1.400595.
| Last Split Date | Jul 5, 2024 |
| Split Type | Forward |
| Split Ratio | 1.400595 |
Scores
Topchoice Medical Co. has an Altman Z-Score of 9.18.
| Altman Z-Score | 9.18 |
| Piotroski F-Score | n/a |